BOSTON — Derek LeRoith, MD, PhD, of the Icahn School of Medicine at Mount Sinai, New York, New York, talks about new therapies for type 2 diabetes at ENDO 2016. Specifically, he discusses a presentation on new oral and injectable therapies during which they presented data on the mechanisms of action and recent cardiovascular outcome studies for the new medications.
